GALT TRADE IDEA - 200ma Support Bounce
Candle over candle confirmation off the 200ma
support bounce with price action crossing our
7ma. RSI moving towards the 50. Look for
price action to move to the 100ma line for
a swing.
GALT has shown an ascending pattern over the last few days and it is soaring over this past trading day (12/29/2017). It broke yesterday’s resistance level and ran up to a high of 3.84 before it started selling off. Moreover, the stock rode the 13EMA for the past few days. It re-tested the 13EMA earlier today before bouncing back up. I re-evaluated a potential...
Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease and cancer. The Company's drug candidates are based on its method of targeting galectin proteins, which are mediators of biologic and pathologic functions. It uses naturally occurring, readily-available plant materials as starting material in manufacturing processes to create complex carbohydrates with specific molecular weights and other pharmaceutical properties. The Company has two product candidates, GR-MD-02 and GM-CT-01. The Company's galectin-3 inhibitor is GR-MD-02. The Company is focusing on development of GR-MD-02 intended to be used in the treatment of liver fibrosis associated with fatty liver disease (NASH), moderate to severe plaque psoriasis and in cancer therapy in combination with immune-system modifying agent(s). GM-CT-01 is a compound that continues to be explored in preclinical studies.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
GALT
